Sharapova returns to the WTA Tour as a wildcard in Stuttgart next week after serving a 15-month ban for a doping offence.
When asked if Sharapova should be given French Open and Wimbledon wildcards, Becker said: "It would be foolish for the biggest tournaments in the world not to offer the most important players wildcards, and she's one of the most important players".
Meanwhile, the five-time Grand Slam champion has also been handed wild cards for Madrid (May 7-13) and Rome (May 15-21) tournaments.
Sharapova, who has titles at all four majors, won at Roland Garros in 2012 and 2014.
During the presentation of the event, the president of the French tennis federation Bernard Giudicelli announced that a final decision will be taken on May 15. This year's French Open starts on May 28 without Serena Williams, who this week announced she is pregnant.
"Williams and Sharapova are two unconnected cases", said Giudicelli.
However, Sharapova could not have picked a better place to make her return.
Sharapova had an initial two-year suspension by the International Tennis Federation cut to 15 months after she tested positive for meldonium at the 2016 Australian Open.
It was a medication Sharapova had been taking when it was legal, but which was later reclassified as a prohibited drug.
"It's a German tournament and we have so many good German players so this is a little odd", said Germany's world number one Angelique Kerber.
She makes her return on Wednesday - the first day she is eligible to play - having been given a wild card for Stuttgart's WTA tournament, with some rivals disapproving of the organisers' decision.
Sharapova, a five-time major champion, is now the 7th ranked player on the WTA tour.
NAN reports that the substance had been added to the World Anti-Doping Agency's list of banned substances in late 2015.